MedCity News

OCTOBER 20, 2024

Pharmaceutical and biotech companies are using generative AI to predict drug-target interactions, optimize lead compounds, and generate novel molecular structures. During the recent MedCity News INVEST Digital Health conference, a panel discussed these applications and more. The post How Generative AI Will Find a Place in the Pharma Industry Now and in the Years to Come appeared first on MedCity News.

Pharma 127

Pharma Leads Pharmaceutical Biopharma 127

pharmaphorum

OCTOBER 20, 2024

At its second attempt, Astellas won FDA approval for its first-in-class cancer therapy, Vyloy, which got the green light for claudin 18.

FDA 69

FDA 69

MedCity News

OCTOBER 20, 2024

Kaiser Permanente is showing no signs of slowing down when it comes to its Risant Health experiment. The organization is currently on the prowl for more acquisition targets, Kaiser CEO Greg Adams said at HLTH. The post Why Greg Adams Believes Risant Health Will Be Successful In Its Mission to Scale VBC Across the Country appeared first on MedCity News.

104

104

PharmaTech

OCTOBER 20, 2024

Bala Addepalli, PhD, Director, R&D New Modalities Portfolio, Waters Corporation, discussed recent advancements and current challenges in the development of large RNA therapeutics.

52

52

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

MedCity News

OCTOBER 20, 2024

Investing in reproductive health is not only a strategic financial move but also a moral imperative. By channeling our investment dollars into the critical areas described above, we can support innovative solutions, expand access to essential services, and uphold the fundamental rights of women across the nation. The post Investing in Reproductive Health Companies Post-Dobbs: A Moral and Strategic Imperative appeared first on MedCity News.

106

106

Pharmaceutical Technology

OCTOBER 20, 2024

While adverse events (AEs) were reported for 97% of trial participants, such cases were predominantly mild to moderate.

52

52

MedCity News

OCTOBER 20, 2024

Research shows that medical residents of all specialties are avoiding states that ban abortion. This was discussed during a panel discussion at Engage at HLTH on Sunday in Las Vegas. The post How the Dobbs Decision Impacts Medical Practice Beyond Just OBGYNs appeared first on MedCity News.

Medical 123

Medical 123

MedCity News

OCTOBER 20, 2024

On the surface, it sounds positively delightful – who wouldn’t want to help dear grandma avoid the nursing home? But as is often the case with these sweeping government proposals, the devil is in the details. The post Why Harris’ Medicare at Home Plan is Good but Flawed appeared first on MedCity News.

Government 97

Government Patients Healthcare Healthcare 97